Farmakokinetikken blev beskrevet hos MabCampath- naive patienter med B- celle kronisk lymfatisk leukæmi (B- CLL), hvor tidligere behandling med purinanaloger havde slået fejl.
Pharmacokinetics were characterised in MabCampath-naive patients with B-cell chronic lymphocytic leukaemia (B-CLL) who had failed previous therapy with purine analogues.